Skip to content

Antibiotic Prophylaxis for TEVAR

Antibiotic Prophylaxis for Thoracic EndoVascular Aortic Repair

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05405790
Enrollment
457
Registered
2022-06-06
Start date
2022-01-01
Completion date
2025-09-01
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Thoracic, Aortic Diseases, Aortic Dissection, Coarctation of Aorta, Hematoma; Aorta

Keywords

Antibiotic prophylaxis, TEVAR, Fever, MAGIC classification

Brief summary

The infection rate of thoracic endovascular aortic repair (TEVAR) is unknown due to a lack of epidemiological data. The rate currently available comes from researches conducted decades ago, when open surgery was the standard of care. Because of the potentially fatal consequences of a stent graft infection in the thoracic aorta, the investigators tend to prescribe antibiotic prophylaxis for at least three days. In this study, the investigators are going to collect data on patients receiving TEVAR in the past five years and provide the following information: a. the infection rate (MAGIC classification), b. the rate of fever, c. the results of the lab tests, such as the WBC count and C-reaction protein. d. risk factors associated with infection and fever.

Interventions

In The TEVAR procedure, we implant a stent graft into the diseased area of the thoracic artery, providing a route for the blood to flow within the stent graft and excluding the diseased aorta.

Sponsors

First Affiliated Hospital of Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with thoracic aortic diseases 2. Received TEVAR

Exclusion criteria

1. Suspected infectious aortic disease, such as a mycotic aneurysm. 2. TEVAR combined with open surgery 3. Antibiotics have been used more than 24 hours before the operation 4. Combined with immune deficiency disease or using hormone or immunosuppressant; 5. The treatment is for the complications of TEVAR, such as endoleak 6. Endovascular aortic repair for abdominal aortic disease 7. History of open aortic surgery or heart surgery. 8. Revascularization of visceral arteries during the TEVAR

Design outcomes

Primary

MeasureTime frameDescription
Infection rate after TEVARduring hospitalization (up to post-operation day 14)Infection rate via MAGIC classification
Infection rate at one month after TEVAROne month after TEVARInfection rate via MAGIC classification
Infection rate at six months after TEVARSix months after TEVARInfection rate via MAGIC classification
Infection rate at one year after TEVAROne year after TEVARInfection rate via MAGIC classification

Secondary

MeasureTime frameDescription
WBC countone day, two days, three days after TEVAR
C-reaction proteinone day after TEVAR
Feverone day, two days, three days, one month, six months, one year after TEVARDefined as temperature ≥38.5℃

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026